Johnson & Johnson

Showing 12 posts of 132 posts found.

J&J chief admits mistakes at Congressional hearing

October 1, 2010
Sales and Marketing Johnson & Johnson, manufacturing compliance, recalls

Johnson & Johnson chief executive William Weldon admitted yesterday that his company had failed to maintain quality standards and mishandled …

J&J’s Weldon will appear at next congressional hearing

September 21, 2010
Manufacturing and Production Johnson & Johnson, manufacturing compliance, recalls

Johnson & Johnson chief executive William Weldon will appear in person at the next congressional hearing on the company’s wide-ranging …

J&J to acquire Crucell for $2.3 billion

September 17, 2010
Sales and Marketing Crucell, Johnson & Johnson

Johnson & Johnson is set to buy out Crucell for around $2.3 billion (1.75 bn euros) expanding its presence in …

J&J and Merck heading for showdown over drug rights

September 8, 2010
Sales and Marketing Johnson & Johnson, Merck, Remicade

Johnson & Johnson’s disagreement with Merck over rights to two arthritis drugs is set to come to a head in …

J&J recall plant will be closed all year

June 29, 2010
Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance

The manufacturing facility at the centre of Johnson & Johnson’s product recall woes is likely to stay closed until at …

Congress summons J&J chief executive

June 23, 2010
Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance

The Congressional committee looking into the recalls ordered by Johnson & Johnson unit McNeil Consumer Healthcare is planning to hold …

J&J expands recall of ‘musty’ products

June 18, 2010
Manufacturing and Production Johnson & Johnson, manufacturing compliance

Johnson & Johnson’s manufacturing troubles continues to build with yet another recall announced this week, this time for additional lots …

‘Phantom recall’ dogs J&J at congressional hearing

June 1, 2010
Manufacturing and Production Johnson & Johnson, McNeil, Tylenol, manufacturing compliance

Johnson & Johnson subsidiary McNeil Consumer Healthcare initiated a recall of its painkiller Motrin (ibuprofen) last year without informing the …

Congress to probe McNeil’s GMP violations

May 7, 2010
Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance

The US Food and Drug Administration may take additional regulatory action against Johnson & Johnson subsidiary McNeil Consumer Healthcare over …

More quality issues dog J&J

May 5, 2010
Manufacturing and Production Johnson & Johnson, manufacturing compliance, recalls

Johnson & Johnson’s manufacturing is under the spotlight at the FDA once again for quality issues affecting its products. At …

Cordis appoints Christian Spaulding

March 30, 2010
Cordis, Johnson & Johnson, appointment, research and development

Johnson & Johnson’s vascular technology company Cordis has appointed Dr Christian Spaulding worldwide VP of medical affairs. He assumes the …

J&J strengthens biotech business

October 24, 2003
Janssen, Janssen Cilag, Johnson & Johnson, Scios

 Johnson & Johnson is to expand its biotech capabilities with a $2.4 billion purchase of US company Scios.The deal, still …

Latest content